| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |